GI & Endoscopy

Gastroenterological cancers, including colorectal cancer, are on the rise across the nation, as the cost of healthcare also continues to rise. 

Gastroenterology groups continue to argue over what age patients should begin screening colonoscopies, with some groups recommending 45, while others recommend 50. 

Physicians and physician groups have expressed concern surrounding procedures, especially those involving anesthesia, in patients taking glucagon-like peptide 1 receptor agonist weight loss medications, including Ozempic. 

Pre- and postoperative colonoscopy care does not increase the risk of periprosthetic joint infection in total joint arthroplasty patients, according to a May 7 study published in JAMA Network. 

Phoenix-based Arizona Digestive Health, an affiliate of GI Alliance, has expanded its presence in Scottsdale, Ariz., through the addition of two new specialists. 

An Illinois bill that would require coverage for all medical necessary colonoscopies is headed to the state Senate, WGEM reported May 9.

Usage of weight loss medications including Glucagon-like peptide-1 receptor agonists such as Ozempic has skyrocketed in the U.S. in the last year, affecting numerous medical specialties. 

Here are three gastroenterology centers that have opened that Becker's has reported on since April 10:

Life sciences company Geneoscopy received FDA approval for its noninvasive colorectal cancer screening test, ColoSense.

San Francisco-based Diatiro Health has won the Society of American Gastrointestinal and Endoscopic Surgeons' 2024 "Shark Tank" competition.